World Bank approves $474 million loans to South Africa for COVID vaccines
June 14 (Reuters) – The World Bank has approved a loan of 454.4 million euros ($474.4 million) to help South Africa fund COVID-19 vaccine purchases, the bank and South Africa’s National Treasury said in a statement.
RELATED ARTICLES:
– Nigeria and South Africa connect to make merry as Tekno and Mafikizolo sings ‘Enjoy’ [MP3 + Video]
– COVID-19: Edochie narrates ordeal, says it damaged his lungs
– Nigerian FinTech company Okra raises $1 million in funding from TLcom Capital
South Africa has recorded the most coronavirus cases and deaths on the African continent, with over 3.9 million confirmed cases and more than 101,000 deaths. It initially struggled to secure vaccines due to limited supplies and protracted negotiations, but it is now well-supplied with doses.
“This project will retroactively finance the procurement of 47 million COVID-19 vaccine doses by the GoSA (Government of South Africa),” the statement said.
The loan is part of government efforts to cut debt-service costs by using cheaper funding sources to respond to the pandemic, Ismail Momoniat, acting director-general of the Treasury,
As of Monday, just over 50% of South Africa’s adult population of around 40 million had received at least one vaccine dose. In recent months the vaccination campaign has slowed, despite efforts to boost take-up.
You may also like to read our recent article, Instagram Beefs Up Child Protection Measures
16 thoughts on “World Bank Approves $474 Million Loan To South Africa For COVID Vaccines”